Exemption number e2019001.The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot.Based on the information reviewed, a conclusive cause for the thrombosis could not be determined.The reported patient effect of thrombosis, as listed in the mitraclip system instructions for use, is a known possible complication associated with mitraclip procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|
This is filed to report tissue damage.It was reported that this was a mitraclip procedure to treat degenerative mitral regurgitation (mr) with a grade of 3-4.The steerable guide catheter (sgc) was inserted into the anatomy; however, during insertion, thrombus was noted in the catheter.The sgc was removed and replaced.The thrombus was also removed with the sgc.It was noted that act remained greater than 250 seconds throughout.Additional heparin was also given.One mitraclip was successfully implanted, reducing mr to a grade of <1.There was no clinically significant delay in the procedure.No additional information was provided.
|